DAPK1 — Death-Associated Protein Kinase 1
Overview
DAPK1 (Death-Associated Protein Kinase 1) encodes a calcium/calmodulin-dependent serine/threonine kinase that functions as a positive regulator of [apoptosis](/entities/apoptosis), [autophagy](/entities/autophagy), and programmed cell death. Originally identified as a pro-apoptotic kinase, DAPK1 has emerged as a critical player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and stroke[@yoo2023].
The kinase is highly expressed in the brain, particularly in neurons, where it integrates calcium signaling with cell death pathways. DAPK1 phosphorylates numerous substrates including [alpha-synuclein](/proteins/alpha-synuclein) at Ser129, [tau](/proteins/tau) proteins, p53, and components of the autophagy machinery. This broad substrate specificity makes DAPK1 a central node connecting multiple neurodegeneration pathways[@ohta2020][@li2022].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | DAPK1 |
| Full Name | Death-Associated Protein Kinase 1 |
| Chromosomal Location | 9p21.3 |
| NCBI Gene ID | 1612 |
| OMIM | 600730 |
| Ensembl ID | ENSG00000196730 |
| UniProt ID | P53355 |
| Encoded Protein | DAPK1 (1056 amino acids) |
| Protein Family | CaMK (Calcium/Calmodulin-dependent protein kinase) family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, stroke, epilepsy, cancer |
</div>
...DAPK1 — Death-Associated Protein Kinase 1
Overview
DAPK1 (Death-Associated Protein Kinase 1) encodes a calcium/calmodulin-dependent serine/threonine kinase that functions as a positive regulator of [apoptosis](/entities/apoptosis), [autophagy](/entities/autophagy), and programmed cell death. Originally identified as a pro-apoptotic kinase, DAPK1 has emerged as a critical player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and stroke[@yoo2023].
The kinase is highly expressed in the brain, particularly in neurons, where it integrates calcium signaling with cell death pathways. DAPK1 phosphorylates numerous substrates including [alpha-synuclein](/proteins/alpha-synuclein) at Ser129, [tau](/proteins/tau) proteins, p53, and components of the autophagy machinery. This broad substrate specificity makes DAPK1 a central node connecting multiple neurodegeneration pathways[@ohta2020][@li2022].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | DAPK1 |
| Full Name | Death-Associated Protein Kinase 1 |
| Chromosomal Location | 9p21.3 |
| NCBI Gene ID | 1612 |
| OMIM | 600730 |
| Ensembl ID | ENSG00000196730 |
| UniProt ID | P53355 |
| Encoded Protein | DAPK1 (1056 amino acids) |
| Protein Family | CaMK (Calcium/Calmodulin-dependent protein kinase) family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, stroke, epilepsy, cancer |
</div>
Protein Structure and Regulation
Domain Architecture
DAPK1 is a multi-domain protein consisting of:
N-terminal Kinase Domain (aa 1-287): Catalytic domain with typical serine/threonine kinase fold
Calmodulin Regulatory Region (aa 288-330): Autoinhibitory domain that binds calmodulin
p53-Binding Domain (aa 331-430): Interacts with tumor suppressor p53
Cytoskeleton-Binding Domain (aa 431-600): Binds actin and microtubules
C-terminal Death Domain (aa 601-1056): Pro-apoptotic signaling domainActivation Mechanism
DAPK1 activity is tightly regulated by calcium/calmodulin binding:
- In resting cells, the calmodulin-regulatory domain autoinhibits kinase activity
- Upon calcium influx, calmodulin binds and relieves autoinhibition
- Sustained calcium signaling leads to persistent DAPK1 activation
- Autophosphorylation at Ser308 maintains activity even after calcium levels normalize
Post-translational Modifications
- Phosphorylation: Multiple sites including Ser308 (autophosphorylation), Thr180 (activation loop)
- Ubiquitination: K63-linked polyubiquitination by TRAF6 promotes kinase activity
- SUMOylation: Modulates subcellular localization and interactions
Normal Physiological Functions
DAPK1 participates in several essential cellular processes:
Apoptosis Induction
- Mediates both extrinsic and intrinsic apoptotic pathways
- Phosphorylates p53 at Ser15, enhancing its transcriptional activity
- Directly activates caspase-3 and caspase-9
- Promotes mitochondrial outer membrane permeabilization (MOMP)
Autophagy Regulation
- Phosphorylates Beclin1 to initiate autophagy
- Modulates ULK1 complex activity
- Participates in both bulk and selective autophagy
- Links autophagy to apoptotic pathways
Cytoskeletal Dynamics
- Modulates actin polymerization and cell motility
- Regulates microtubule dynamics
- Influences cell shape and process extension in neurons
Inflammation and Immunity
- Regulates cytokine production in immune cells
- Modulates NF-κB signaling
- Participates in microglial activation
Role in Alzheimer's Disease
DAPK1 has emerged as a significant contributor to Alzheimer's disease pathogenesis through multiple mechanisms:
Amyloid-beta Induced Neurotoxicity
DAPK1 is upregulated in Alzheimer's disease brains and mediates Aβ-induced neuronal death[@yoo2023]:
- Aβ exposure triggers DAPK1 activation via calcium dysregulation
- DAPK1 phosphorylates p53, enhancing pro-apoptotic gene expression
- DAPK1 deficiency protects neurons from Aβ toxicity in vitro
- DAPK1 knockout mice show reduced neuronal loss in APP/PS1 models
Tau Pathology
DAPK1 phosphorylates tau at multiple sites relevant to AD pathology[@zhang2022][@xu2024]:
- Direct phosphorylation of tau at Ser262 and Ser396
- DAPK1 activity correlates with tau phosphorylation in AD brains
- DAPK1-mediated tau phosphorylation promotes NFT formation
- DAPK1 inhibition reduces tau pathology in animal models
Synaptic Dysfunction
- DAPK1 activation disrupts synaptic plasticity
- Impairs LTP (Long-Term Potentiation) in hippocampal neurons
- Reduces dendritic spine density
- Contributes to memory deficits
Neuroinflammation
DAPK1 in microglia contributes to neuroinflammation[@wang2024]:
- Promotes pro-inflammatory cytokine production
- Enhances NF-κB activation in glial cells
- Creates feedback loop between inflammation and neuronal death
- DAPK1 in microglia may represent therapeutic target
Calcium Dysregulation
AD features prominent calcium dysregulation that activates DAPK1[@yang2023]:
- Amyloid-beta disrupts calcium homeostasis
- Elevated intracellular calcium directly activates DAPK1
- DAPK1 activation creates feed-forward neurodegeneration
- Calcium channel blockers reduce DAPK1 activation
Role in Parkinson's Disease
Alpha-synuclein Phosphorylation
The most significant finding linking DAPK1 to PD is the phosphorylation of α-synuclein at Ser129[@ohta2020]:
- DAPK1 directly phosphorylates α-synuclein at Ser129
- Phosphorylation promotes formation of insoluble aggregates
- DAPK1 enhances rotenone-induced α-synuclein aggregation
- pSer129 α-synuclein is a hallmark of Lewy bodies in PD brains
- DAPK1 inhibition reduces α-synuclein aggregation in cellular models
Mitochondrial Dysfunction
DAPK1 contributes to mitochondrial impairment in PD[@fan2022]:
- DAPK1 activation promotes mitochondrial fragmentation
- Impairs complex I activity in dopaminergic neurons
- Enhances ROS production
- Contributes to PINK1/Parkin pathway dysfunction
Dopaminergic Neuron Survival
- DAPK1 is activated in MPTP and 6-OHDA PD models
- DAPK1 knockout mice show resistance to MPTP toxicity
- DAPK1-mediated apoptosis in dopaminergic neurons
- Genetic variants in DAPK1 may influence PD susceptibility[@yu2021]
Autophagy Impairment
- DAPK1 dysregulates autophagy in PD
- Abnormal autophagy contributes to α-synuclein accumulation
- DAPK1 inhibition restores autophagy flux
- Therapeutic potential of DAPK1 modulators
Role in Stroke and Brain Injury
Ischemic Injury
DAPK1 mediates neuronal death after stroke[@yamamoto2019]:
- Ischemia triggers rapid DAPK1 activation
- DAPK1 deletion reduces infarct size in mouse models
- DAPK1 inhibitors are neuroprotective in stroke models
- DAPK1 acts upstream of both apoptosis and necroptosis
Excitotoxicity
- Glutamate excitotoxicity activates DAPK1
- NMDA receptor overactivation leads to DAPK1-dependent death
- DAPK1 links excitotoxicity to apoptotic pathways
- Calcium influx is the primary activator
Therapeutic Targeting
DAPK1 inhibition represents a therapeutic strategy for stroke:
- Small molecule DAPK1 inhibitors show promise
- Neuroprotective effects in pre-clinical models
- Extended therapeutic window compared to other approaches
Therapeutic Implications
DAPK1 Inhibitors
Multiple DAPK1 inhibitors have been developed[@song2023]:
- ATP-competitive inhibitors block kinase activity
- Peptide inhibitors targeting protein-protein interactions
- Natural products with DAPK1 inhibitory activity
- Challenges include blood-brain barrier penetration
Combination Therapies
- DAPK1 inhibitors with existing AD therapeutics
- Synergy with anti-amyloid and anti-tau approaches
- Multi-target strategies for complex neurodegeneration
Biomarker Potential
- DAPK1 activity as a disease biomarker
- CSF DAPK1 measurement in neurodegenerative diseases
- Monitoring therapeutic response
Expression Patterns
Brain Expression
- High expression: Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [basal ganglia](/brain-regions/basal-ganglia), [cerebellum](/brain-regions/cerebellum)
- Cellular localization: Primarily cytosolic, with nuclear translocation upon activation
- Cell type specificity: Neurons, astrocytes, microglia
Peripheral Expression
- Moderate expression in lung, heart, immune cells
- Differential expression in various tissues
Signaling Pathways
DAPK1 interacts with multiple signaling pathways:
Mermaid diagram (expand to render)
Key Protein Interactions
| Interacting Protein | Function | Disease Relevance |
|---------------------|----------|-------------------|
| p53 | Tumor suppressor, apoptosis | AD, PD |
| Beclin1 | Autophagy initiation | AD, PD |
| Alpha-synuclein | Lewy body component | PD |
| Tau | NFT component | AD |
| ULK1 | Autophagy initiation | AD, PD |
| RIPK1 | Necroptosis | Stroke |
Research Directions
Current Research Focus
Structural studies: DAPK1 kinase domain structure for drug design
Substrate identification: Broader mapping of DAPK1 substrates
Animal models: Conditional knockout and knock-in models
Biomarker development: Clinical validation of DAPK1 as biomarkerUnresolved Questions
- Specific contribution of DAPK1 to different neurodegenerative diseases
- Cell-type specific functions (neurons vs. glia)
- Relationship between DAPK1 and other kinases (e.g., CDK5, GSK3β)
- Optimal timing for therapeutic intervention
Cross-Links
- [Apoptosis](/entities/apoptosis) — DAPK1 as pro-apoptotic kinase
- [Autophagy](/mechanisms/autophagy) — DAPK1 in autophagic cell death
- [Alpha-synuclein](/proteins/alpha-synuclein) — DAPK1 phosphorylates α-syn at Ser129
- [Tau](/proteins/tau) — DAPK1 phosphorylates tau
- [Neuroinflammation](/mechanisms/neuroinflammation) — DAPK1 in glial activation
- [Calcium signaling](/mechanisms/calcium-dysregulation) — DAPK1 activation trigger
- [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) — DAPK1 effects on mitochondria
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Major disease association
- [Parkinson's Disease](/diseases/parkinsons-disease) — α-synuclein phosphorylation
- [Stroke](/diseases/stroke) — Ischemic neuronal injury
- [p53 (TP53)](/genes/tp53) — DAPK1 phosphorylates p53
- [Beclin1 (BECN1))](/genes/becn1) — DAPK1 regulates autophagy
- [ULK1](/genes/ulk1) — DAPK1 interacts with autophagy initiation complex
- [SNCA](/genes/snca) — Alpha-synuclein gene, DAPK1 substrate
Summary
DAPK1 represents a critical molecular link between calcium dysregulation and neurodegeneration. Its ability to phosphorylate key proteins including α-synuclein, tau, and p53 positions it as a central mediator of cell death pathways in AD, PD, and stroke. The kinase's involvement in multiple disease mechanisms makes it an attractive therapeutic target, though drug development challenges remain. Ongoing research continues to elucidate DAPK1's precise contributions to neurodegeneration and explore its potential for disease modification.
See Also
- [Genes Section](/genes)
- [Proteins Section](/proteins)
- [Mechanisms Section](/mechanisms)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/1612)
- [UniProt Protein Database](https://www.uniprot.org/uniprot/P53355)
- [Ensembl Gene Database](https://www.ensembl.org/Homo_sapiens/ENSG00000196730)
- [PubMed Literature](https://pubmed.ncbi.nlm.nih.gov/?term=DAPK1+neurodegeneration)
References
[Yoo MS et al., DAPK1 mediates neurodegeneration in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37047515/)
[Ohta K et al., DAPK1 phosphorylates alpha-synuclein at Ser129 in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32624505/)
[Li X et al., DAPK1 as a therapeutic target for neuroprotection (2022)](https://pubmed.ncbi.nlm.nih.gov/35642062/)
[Shen Y et al., Role of DAPK1 in neuronal apoptosis and neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/30660031/)
[Yamamoto M et al., DAPK1 inhibition protects against ischemic neuronal injury (2019)](https://pubmed.ncbi.nlm.nih.gov/31055148/)
[Chen Y et al., DAPK1 deficiency attenuates neurodegeneration in AD models (2019)](https://pubmed.ncbi.nlm.nih.gov/31154020/)
[Liu J et al., DAPK1-mediated autophagy in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34213316/)
[Wang X et al., DAPK1 and neuroinflammation in neurodegenerative disorders (2024)](https://pubmed.ncbi.nlm.nih.gov/38476523/)
[Yang L et al., Calcium dysregulation and DAPK1 activation in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36740992/)
[Zhang Y et al., DAPK1 in tauopathy (2022)](https://pubmed.ncbi.nlm.nih.gov/36209145/)
[Yu P et al., DAPK1 genetic variants and susceptibility to Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33773219/)
[Li R et al., DAPK1 interacts with p53 in neuronal apoptosis (2020)](https://pubmed.ncbi.nlm.nih.gov/32185642/)
[Song Y et al., DAPK1 inhibitors as therapeutic agents for neurodegenerative diseases (2023)](https://pubmed.ncbi.nlm.nih.gov/37078912/)
[Xu W et al., DAPK1-mediated phosphorylation of tau in AD models (2024)](https://pubmed.ncbi.nlm.nih.gov/38289734/)
[Fan Z et al., DAPK1 modulates mitochondrial dysfunction in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35605423/)
[He L et al., DAPK1 and the unfolded protein response in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/37528891/)
[Guo Q et al., Targeting DAPK1 for early diagnosis and treatment in AD (2024)](https://pubmed.ncbi.nlm.nih.gov/38642178/)Pathway Diagram
The following diagram shows the key molecular relationships involving DAPK1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)